SCHEMBL5173947

SCHEMBL5173947

COc1ccc([N+](=O)[O-])c(-n2ncccc2=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ KMT2A Q03164 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ POLB P06746 1/20 0.42
▸ NPC1 O15118 3/20 0.41
▸ GAA P10253 3/20 0.40
▸ HTT P42858 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ AKR1B10 O60218 1/20 0.39
▸ AKR1B1 P15121 1/20 0.39
▸ AKR1C4 P17516 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18770625 0.80 NPBWR1 (0.43) ALDH1A1MAPTSMN1; SMN2
SCHEMBL2061964 0.79 ALDH1A1 (0.61) ALDH1A1MAPK1KMT2AMAPTMEN1
SCHEMBL25027280 0.77 GAA (0.45) ALDH1A1MAPK1KMT2AMAPTMEN1
SCHEMBL31053862 0.77 GAA (0.45) ALDH1A1MAPK1KMT2AMAPTMEN1
SCHEMBL2483950 0.75 HTR6 (0.62) ALDH1A1MAPK1MAPTHTT
SCHEMBL12205180 0.75 HTR6 (0.36) ALDH1A1MAPK1KMT2AMAPTMEN1
SCHEMBL30657603 0.74 ALDH1A1 (0.52) ALDH1A1MAPK1MAPTPOLBNPC1
SCHEMBL29126953 0.74 ALDH1A1 (0.52) ALDH1A1MAPK1MAPTPOLBNPC1
SCHEMBL30745155 0.72 MGLL (0.50) ALDH1A1MAPK1KMT2AMAPTMEN1
SCHEMBL29151112 0.72 MGLL (0.50) ALDH1A1MAPK1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737826-A1 ALPHA-4 INTEGRIN MEDIATED CELL ADHESION INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY DISEASES TANABE SEIYAKU CO., LTD. (JP) 2007-01-03 — — EP disclosed
WO-2005075438-A1 ALPHA-4 INTEGRIN MEDIATED CELL ADHESION INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY DISEASES TANABE SEIYAKU CO., LTD. (JP) 2005-08-18 — — WO disclosed
Send feedback